Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N W Gibson

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Cancer Research|February 15, 1992
NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivityR D Traver, T Horikoshi, K D Danenberg, et al.
British Journal of Cancer|January 1, 1997
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase)R D Traver, D Siegel, H D Beall, et al.
Journal of Medicinal Chemistry|February 1, 1984
Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agentM F Stevens, J A Hickman, R Stone, et al.
Biochemistry|December 17, 1991
DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reductionJ A Hartley, M Berardini, M Ponti, et al.
Cancer Research|July 1, 1985
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agentJ A Hickman, M F Stevens, N W Gibson, et al.
Cancer Research|November 15, 1987
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazineM F Stevens, J A Hickman, S P Langdon, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Cancer Research|February 15, 1992
NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivityR D Traver, T Horikoshi, K D Danenberg, et al.
British Journal of Cancer|January 1, 1997
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase)R D Traver, D Siegel, H D Beall, et al.
Journal of Medicinal Chemistry|February 1, 1984
Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agentM F Stevens, J A Hickman, R Stone, et al.
Biochemistry|December 17, 1991
DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reductionJ A Hartley, M Berardini, M Ponti, et al.
Cancer Research|July 1, 1985
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agentJ A Hickman, M F Stevens, N W Gibson, et al.
Cancer Research|November 15, 1987
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazineM F Stevens, J A Hickman, S P Langdon, et al.
Pageof 7